Dynamic HER2-low status among patients with triple negative breast cancer (TNBC): The impact of repeat biopsies

被引：0
|
作者：
Bar, Yael
Dedeoglu, Aylin S.
Fell, Geoffrey G.
Moffett, Natalie J.
Boyraz, Baris
Ly, Amy
Bardia, Aditya
Moy, Beverly
Ellisen, Leif W.
Isakoff, Steven J.
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA USA
[3] Massachusetts Gen Hosp Canc Ctr, Boston, MA USA
[4] Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1005
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The effect of eribulin treatment for patients with HER2-low breast cancer
    Goto, Wataru
    Henmi, Saeko
    Nishikawa, Mariko
    Kouchi, Asuka
    Kouhashi, Rika
    Yabumoto, Akimichi
    Takada, Koji
    Asano, Yuka
    Tauchi, Yukie
    Ogisawa, Kana
    Morisaki, Tamami
    Kashiwagi, Shinichiro
    CANCER RESEARCH, 2024, 84 (09)
  • [42] The Effect of HER2-Low Status on Pathological Complete Response and Survival in Triple-Negative Breast Cancer: A Systemic Review and Meta-Analysis
    Ergun, Yakup
    Akagunduz, Baran
    Karacin, Cengiz
    Turker, Sema
    Ucar, Gokhan
    CLINICAL BREAST CANCER, 2023, 23 (06) : 567 - 575
  • [43] Prognostic value of HER2-low expression according to hormone receptor status in breast cancer patients
    Huszno, J.
    Kolosza, Z.
    Stobiecka, E.
    Ponikiewska, D.
    Szczesniak, B.
    Simek, J.
    Chmielik, E.
    BREAST, 2025, 80
  • [44] Trastuzumab Deruxtecan in HER2-Low Breast Cancer
    Ferhanoglu, Burhan
    Atesoglu, Elif Birtas
    Ozbalak, Murat
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (12) : 1147 - 1147
  • [45] Overall survival in breast cancer patients with HER2-low status single- center experience
    Huszno, J.
    Kolosza, Z.
    Stobiecka, E.
    Ponikiewska, D.
    Szczesniak, B.
    Simek, J.
    Chmielik, E.
    ANNALS OF ONCOLOGY, 2023, 34 : S1190 - S1190
  • [46] The Clinicopathological Features and Prognostic Significance of HER2-Low in Early Breast Tumors Patients Prognostic Comparison of HER-Low and HER2-Negative Breast Cancer Stratified by Hormone Receptor Status
    Gamrani, Sanaa
    Akhouayri, Laila
    Boukansa, Sara
    Karkouri, Mehdi
    El Fatemi, Hinde
    BREAST JOURNAL, 2023, 2023
  • [47] Exploring HER2-low disease: Does it impact breast cancer survival?
    Lopez-Paradis, Assumpcio
    Pous, Anna
    Bernat-Peguera, Adria
    Quiroga, Vanesa
    Cirauqui, Beatriz
    Felip, Eudald
    Bergamino, Milana
    Ferrando-Diez, Angelica
    Romeo, Marga
    Teruel, Iris
    Martinez-Cardus, Anna
    Margeli, Mireia
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] HER2-Low Breast Cancer: a New Subtype?
    Corti, Chiara
    Giugliano, Federica
    Nicolo, Eleonora
    Tarantino, Paolo
    Criscitiello, Carmen
    Curigliano, Giuseppe
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (05) : 468 - 478
  • [49] HER2-Low Breast Cancer: Now and in the Future
    Kang, Sora
    Kim, Sung-Bae
    CANCER RESEARCH AND TREATMENT, 2024, 56 (03): : 700 - 720
  • [50] HER2-Low Breast Cancer: a New Subtype?
    Chiara Corti
    Federica Giugliano
    Eleonora Nicolò
    Paolo Tarantino
    Carmen Criscitiello
    Giuseppe Curigliano
    Current Treatment Options in Oncology, 2023, 24 : 468 - 478
12345